<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3294">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04460599</url>
  </required_header>
  <id_info>
    <org_study_id>Brain COVID</org_study_id>
    <nct_id>NCT04460599</nct_id>
  </id_info>
  <brief_title>Neurological Features During COVID19</brief_title>
  <acronym>NeuroSARS</acronym>
  <official_title>Description of neurolOgical Involvement Observed During SARS COV2 Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d'Investigation Clinique et Technologique 805</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre d'Investigation Clinique et Technologique 805</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Description of the neurological impairment: clinico-radiological and electrophysilogical
      correlations
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Describe short and long term clinical radiological and electrophysilogical presentations of
      neurological damage central and peripheral SARS COV2 infection Describe the association
      between neurological, respiratory and dysautonomic Determine the prognosis of neurological
      damages to short and long term.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 8, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Primary</measure>
    <time_frame>6 months</time_frame>
    <description>incidence of objective neurological damage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary</measure>
    <time_frame>6 months</time_frame>
    <description>incidence of clinical neurological damage incidence of radiological neurological damage incidence of neurophysiological neurological damage</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Encephalitis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>Observation of recorded neurological signs</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Population hospitalized in ICU for COVID 19.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PCR SARS COV2 positive or CT Scan

          -  Central neurological signs such as confusion, epilepsy, abnormal movement, pyramidal
             signs, motor or sensory deficit, involvement of cranial pairs (such as anomie or
             ageusia) or peripheral.

          -  Dysautonomic signs such as hypotension or hypertension, bradycardia or tachycardia,
             hypothermia, SIADH not explained by therapy or a pathology other than SARS COV 2
             infection

        Exclusion Criteria:

          -  Contraindication to performing an MRI scan

          -  Minor

          -  Pregnant woman

          -  No follow-up possible at 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>David Orlikowski, MD PhD</last_name>
    <phone>0147107777</phone>
    <email>david.orlikowski@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isabelle Bossard</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopital Raymond Poincare</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DAVID ORLIKOWSKI, MD PHD</last_name>
      <phone>(33)147107777</phone>
      <email>david.orlikowski@rpc.aphp.fr</email>
    </contact>
    <contact_backup>
      <phone>(33)147104469</phone>
    </contact_backup>
    <investigator>
      <last_name>DAVID ORLIKOWSKI, MD PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric Azabou, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie Christine Durand, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Carlier, MD PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 6, 2020</study_first_submitted>
  <study_first_submitted_qc>July 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2020</study_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre d'Investigation Clinique et Technologique 805</investigator_affiliation>
    <investigator_full_name>david orlikowski</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Cranial nerves</keyword>
  <keyword>brainstem</keyword>
  <keyword>dysautonomia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Encephalitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

